INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 27 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
Q2 2023 | $4,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
Q1 2023 | $4,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
Q4 2022 | $4,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
Q3 2022 | $4,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
Q2 2022 | $4,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
Q4 2021 | $4,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
Q3 2021 | $4,000 | -99.9% | 4,000 | -99.9% | 0.00% | -100.0% |
Q1 2021 | $6,484,000 | +5.1% | 5,825,000 | +5.9% | 0.00% | 0.0% |
Q4 2020 | $6,172,000 | +102766.7% | 5,500,000 | +78471.4% | 0.00% | – |
Q1 2020 | $6,000 | -14.3% | 7,000 | 0.0% | 0.00% | – |
Q4 2019 | $7,000 | +16.7% | 7,000 | 0.0% | 0.00% | – |
Q3 2019 | $6,000 | -14.3% | 7,000 | 0.0% | 0.00% | – |
Q2 2019 | $7,000 | +75.0% | 7,000 | +75.0% | 0.00% | – |
Q1 2019 | $4,000 | +33.3% | 4,000 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
Q3 2018 | $3,000 | – | 4,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |